We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Microsaic Systems Plc | LSE:MSYS | London | Ordinary Share | GB00BMWC8365 | ORD GBP0.00001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.225 | 1.20 | 1.25 | 1.25 | 1.20 | 1.25 | 35 | 08:00:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Components, Nec | 1.57M | -2.29M | -0.0128 | -0.95 | 2.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2013 12:30 | why all the trading today (big volume compared to normal)? | andrbea | |
21/10/2013 06:14 | RNSNON this morning re formation of scientific advisory group - | johnwall | |
18/4/2012 12:14 | rns today about an expo all very well, but why no trading update? how many spectrometers do they sell to labs each quarter (geographic sales split etc...) | andrbea | |
03/11/2011 19:01 | Also understand that Galvan gave a very positive recommendation on this earlier today. Not a bad sign. | mandm10 | |
03/11/2011 11:13 | Saffery Champness acted as the reporting accountant on the April listing of pharmaceutical technology firm Microsaic Systems in a deal that raised £4 million. Despite the risks associated with bringing any new technology to the market, there were a number of factors that seemed to give investors confidence, says Patel. 'A level of assurance was generated by product development being carried out in partnership with leading pharmaceuticals businesses. With the technology being patented and having the potential for a wide range of applications, there are also opportunities for the company to diversify sales into a number of different markets.' | andrbea | |
19/10/2011 11:47 | msys 7% 19/10/2011 12:42:33 MSYS 29.50 O 10,000 19/10/2011 12:28:07 MSYS 29.70 O 1,683 19/10/2011 11:45:00 MSYS 29.50 O 400 19/10/2011 11:39:39 MSYS 29.10 O 10,000 19/10/2011 11:26:02 MSYS 27.00 O 2,000 | andrbea | |
09/8/2011 07:42 | up 3% APPOINTMENT OF SAMANTHA DUNNAGE TO LEAD DIRECT PRODUCT SALES 8 August 2011: Microsaic Systems plc (AIM: MSYS), the developer of chip-based scientific instruments, today announces that Samantha Dunnage has joined to lead the Company's marketing and direct sales. Samantha joins Microsaic Systems from Uniqsis Ltd where she successfully launched and grew sales of innovative solutions to customers from the pharmaceutical industry across the USA and Europe. | andrbea | |
10/5/2011 15:22 | Bulford talking this stock | pavsmommy | |
18/4/2011 15:03 | Nigel Wray selling ? | bonanza grades | |
12/4/2011 23:02 | Certainly seems to be some interest. 42p from a 32p placing price. | bonanza grades | |
12/4/2011 09:40 | MICROSAIC WILL BRING A WORLD FIRST TO AIM Read more: TECHNOLOGY specialist Microsaic Systems, pioneer of the world's only mini-mass spectrometer, is listing on Aim this month. The company will be the first technology group to join the market this year when it floats next week, raising £4million. A spin-out from Imperial College London, Microsaic will have a market value of £12million and has been advised by Numis Securities. Its desktop device the Microsaic 3500 can runs tests for chemicals in liquids, gases and solids. Microsaic says it is smaller, lighter, cheaper and more energy efficient than conventional systems, and is protected by worldwide patents. The company works with blue chip partners in the pharmaceuticals sector and the Ministry of Defence, but its invention is also employed by US Homeland Security to test for explosives in fluids at airports. Serial investor Nigel Wray holds a 7.21 per cent stake in Microsaic. Microsaic says it is smaller, lighter, cheaper and more energy efficient than conventional systems The total mass spectrometer market is currently worth £2billion but future growth, forecast at 8.5 per cent over the next 12 months, is likely to be in the food and drink industry. Chief executive Alan Finlay says the firm has taken calls from vineyard owners, who want to test the age of their wine. He also hopes to gain work from food manufacturers, who face growing health and safety regulation, to test for product contamination. Microsaic says scandals such as the poisoning of Austrian wine with anti-freeze in the mid-1980s and the 2005 contamination of food by the carcinogen red dye Sudan 1, would never have happened if mass spectrometers had been in use. | andrbea | |
12/4/2011 07:04 | up 2% it's a start.. :-) | andrbea | |
11/4/2011 22:09 | FT comment Microsaic Systems, the first technology company to join Aim this year, made a strong debut. Placed at 32p following a £4m placing, its shares came to rest at 40; Microsaic Systems has developed a miniature chip-based mass spectrometer. | bonanza grades | |
11/4/2011 13:35 | Decent start for MSYS | bonanza grades | |
11/4/2011 13:12 | Floated April 11th on AIM | andrbea | |
11/4/2011 06:54 | Admission to Trading 11 April 2011... Microsaic Systems plc, the developer of miniaturised chip-based scientific instruments, is pleased to announce that admission to trading on AIM will become effective, and dealings in the ordinary shares of the Company will start, at 8.00am today, 11 April 2011, under the ticker symbol "MSYS". The Admission to AIM follows the Company's successful fund raising, which raised gross proceeds of £4 million by way of an institutional placing of 12,500,000 new shares to institutional investors at 32p per share. On Admission, Microsaic will have a market capitalisation of approximately £12 million. The net proceeds of the Placing will be used by the Company to fund capital expenditure, manufacturing, sales and field support and new product development, as well as ongoing working capital requirements. Numis Securities Limited is Nominated Advisor and Broker to Microsaic. Alan Finlay, chief executive of Microsaic Systems plc, said: "I am very proud of the progress that our team at Microsaic has made over the past ten years. We have developed a first-to-market position with our novel chip-based mass spectrometer detectors, which we believe will enable us to exploit a large market opportunity across multiple sectors. This is a great achievement and I would like to thank everyone involved for their efforts. I believe this new stage of the Company's evolution will herald the continued growth and development of our business and the creation of further value for our shareholders." The Business Microsaic is the first and only company to have successfully miniaturised mass spectrometry ("MS") through the development of its patented chip-based technologies (ionchip®, spraychip® and vac-chip®). The Company's first product, the Microsaic 3500 MiD®, was launched in January 2011. It is a desktop MS system that is smaller, lighter, more energy efficient and cheaper to run than legacy MS systems. · Mass spectrometry is widely accepted as a 'gold-standard' method for identifying chemicals. As a result, this technique is used routinely by chemists across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food and drink, healthcare and industrial chemicals. · The total MS market was worth c. US$3.3 billion p.a. (August 2010) and is forecast to grow 8.5% between 2010 and 2011 (Mass spectrometry market data, SDI, March 2011). More than two-thirds of this highly diversified market is directly or indirectly tied to government, healthcare and regulation-driven demand, such as drug development, diagnostics, food and environmental safety testing. · Microsaic aims to introduce compact, deployable MS products, based on its core technology, into a series of target markets. · In addition, the Company continues to innovate and develop next generation products designed to reach wider markets and target additional applications, providing even greater sensitivity for detecting very low concentrations of chemicals (e.g. contaminants, harmful substances or clinical biomarkers) in complex samples (e.g. urine, blood plasma and food). · Microsaic Systems was established in 2001 as a spin out from Imperial College London. · Microsaic's technologies are protected by 88 patent applications worldwide of which 36 are granted. Admission Statistics Number of Placing Shares 12,500,000 Placing Price 32 pence Estimated gross proceeds from the Placing of New Shares £4 million Enlarged Issued Share Capital immediately following Admission 37,515,400 Percentage of Enlarged Issued Share Capital represented by the New Shares 33.32 per cent. Market capitalisation of the Company immediately following Admission at the Placing Price £12 million ISIN GB00B547ZY09 AIM Symbol MSYS | bonanza grades |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions